Mother and Child Image

News

CMV research is an emerging field, but there are a variety of studies, clinical trials, and legislation underway.  The National CMV Foundation is dedicated to providing the necessary CMV research data, support and information to help you further the efforts to overcoming CMV.

Legislation

Empowered CMV families from across the nation have teamed up with professionals and politicians in several states in hopes of making a difference with CMV legislation!


Learn More

Physician's Information

CMV can be a serious problem for babies who are infected before birth. This is referred to as congenital CMV and it occurs when a pregnant woman passes the virus to her unborn child.


Learn More

Studies

In these last 55 years, definite strides have been made in the field of CMV research, including the development and administration of antiviral treatments and vaccine candidates.


Learn More

Treatments

Recent studies indicate that CMV-IGIV treatment may reduce the risk of congenital infection and/or neonatal disease when given to pregnant women experiencing a primary CMV infection.


Learn More

Vaccines

There is no CMV vaccine available to prevent congenital CMV. Many experts believe that a CMV vaccine is possible within the next 10 to 20 years, but a CMV vaccine is unlikely to occur without the awareness.


Learn More

Registries

The purpose of the National Cytomegalovirus Registry for Pregnant Women is to develop a database of nearly all pregnant women in the U.S. who develop a congenital infection during pregnancy.


Learn More